Common Contracts
15 similar Sales Agreement contracts by Nautilus Biotechnology, Inc., Alector, Inc., Anaptysbio, Inc, others
Repare therapeutics inc. Common Shares SALES AGREEMENTSales Agreement • November 7th, 2024 • Repare Therapeutics Inc. • Pharmaceutical preparations • New York
ANAPTYSBIO, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 5th, 2024 • Anaptysbio, Inc • Pharmaceutical preparations • New York
BIODESIX, INC. SHARES OF COMMON STOCK SALES AGREEMENTSales Agreement • November 1st, 2024 • Biodesix Inc • Services-medical laboratories • New York
DIANTHUS THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • October 1st, 2024 • Dianthus Therapeutics, Inc. /DE/ • Pharmaceutical preparations • New York
SERA PROGNOSTICS, INC. $50,000,000 OF SHARES OF CLASS A COMMON STOCK SALES AGREEMENTSales Agreement • August 7th, 2024 • Sera Prognostics, Inc. • Services-medical laboratories • New York
Immunome, Inc. $200,000,000 SALES AGREEMENTSales Agreement • May 14th, 2024 • Immunome Inc. • Pharmaceutical preparations • New York
MADRIGAL PHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • May 7th, 2024 • Madrigal Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
MDxHealth SA ORDINARY SHARES SALES AGREEMENTSales Agreement • May 1st, 2024 • MDxHealth SA • Services-medical laboratories • New York
GENEDX HOLDINGS CORP. $75,000,000 CLASS A COMMON STOCK SALES AGREEMENTSales Agreement • April 29th, 2024 • GeneDx Holdings Corp. • Services-health services • New York
MORPHIC HOLDING, INC. SALES AGREEMENTSales Agreement • April 26th, 2024 • Morphic Holding, Inc. • Pharmaceutical preparations • New York
EXSCIENTIA PLC AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES SALES AGREEMENTSales Agreement • March 21st, 2024 • Exscientia PLC • Biological products, (no disgnostic substances) • New York
Exscientia plc, a public limited company incorporated under the laws of England and Wales with company number 13483814 (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
VTV THERAPEUTICS INC. CLASS A COMMON STOCK SALES AGREEMENTSales Agreement • February 28th, 2024 • vTv Therapeutics Inc. • Pharmaceutical preparations • New York
NAUTILUS BIOTECHNOLOGY, INC. SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE SALES AGREEMENTSales Agreement • February 28th, 2024 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments • New York
Nautilus Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
NAUTILUS BIOTECHNOLOGY, INC. SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE SALES AGREEMENTSales Agreement • February 28th, 2024 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments • New York
Nautilus Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“TD Cowen”), as follows:
ALECTOR, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 7th, 2023 • Alector, Inc. • Biological products, (no disgnostic substances) • New York
